Fujian Aonong Biological Technology Group Incorporation Ltd (603363) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥29.28 Million ≈ $4.28 Million USD) by net assets (CN¥3.79 Billion ≈ $553.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Fujian Aonong Biological Technology Grou (603363) total market value for the company's overall valuation and market capitalisation.

Fujian Aonong Biological Technology Group Incorporation Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Fujian Aonong Biological Technology Group Incorporation Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Fujian Aonong Biological Technology Group Incorporation Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fujian Aonong Biological Technology Group Incorporation Ltd ranked by their cash flow conversion efficiency. Explore Fujian Aonong Biological Technology Grou (603363) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Tianjin Ringpu Bio Tech
SHE:300119
0.020x
MRC Global Inc
NYSE:MRC
-0.070x
Marcus & Millichap Inc
NYSE:MMI
0.048x
TF Bank AB
ST:TFBANK
-0.024x
Maoye Commercial Co Ltd
SHG:600828
-0.003x
Guangdong South New Media Co Ltd
SHE:300770
-0.010x
Avanos Medical Inc
NYSE:AVNS
-0.016x
Goldcup Electric Apparatus Co Ltd
SHE:002533
-0.011x

Annual Cash Flow Conversion Efficiency for Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2025. View Fujian Aonong Biological Technology Grou (603363) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.58 Billion
≈ $523.90 Million
CN¥152.94 Million
≈ $22.38 Million
0.043x +211.98%
2024-12-31 CN¥3.06 Billion
≈ $447.94 Million
CN¥-116.78 Million
≈ $-17.09 Million
-0.038x +98.05%
2023-12-31 CN¥-503.22 Million
≈ $-73.64 Million
CN¥984.01 Million
≈ $143.99 Million
-1.955x -1111.25%
2022-12-31 CN¥3.43 Billion
≈ $502.21 Million
CN¥663.64 Million
≈ $97.11 Million
0.193x -19.12%
2021-12-31 CN¥2.19 Billion
≈ $320.90 Million
CN¥524.29 Million
≈ $76.72 Million
0.239x +129.83%
2020-12-31 CN¥3.90 Billion
≈ $571.16 Million
CN¥406.02 Million
≈ $59.41 Million
0.104x -66.13%
2019-12-31 CN¥1.28 Billion
≈ $187.83 Million
CN¥394.16 Million
≈ $57.68 Million
0.307x +1036.50%
2018-12-31 CN¥1.01 Billion
≈ $147.64 Million
CN¥27.26 Million
≈ $3.99 Million
0.027x -2.57%
2017-12-31 CN¥965.55 Million
≈ $141.29 Million
CN¥26.78 Million
≈ $3.92 Million
0.028x -87.23%
2016-12-31 CN¥593.75 Million
≈ $86.88 Million
CN¥128.95 Million
≈ $18.87 Million
0.217x -25.15%
2015-12-31 CN¥445.39 Million
≈ $65.17 Million
CN¥129.24 Million
≈ $18.91 Million
0.290x +285.28%
2014-12-31 CN¥214.94 Million
≈ $31.45 Million
CN¥-33.66 Million
≈ $-4.93 Million
-0.157x -112.13%
2013-12-31 CN¥106.35 Million
≈ $15.56 Million
CN¥137.26 Million
≈ $20.09 Million
1.291x --

About Fujian Aonong Biological Technology Group Incorporation Ltd

SHG:603363 China Farm Products
Market Cap
$1.17 Billion
CN¥8.00 Billion CNY
Market Cap Rank
#8297 Global
#1951 in China
Share Price
CN¥2.93
Change (1 day)
-1.01%
52-Week Range
CN¥2.63 - CN¥5.80
All Time High
CN¥26.65
About

Fujian Aonong Biological Technology Group Incorporation Limited engages in the feed, pig farming, food, supply chain services, and other businesses in China and internationally. It researches and develops, produces, and sells feed products, such as pig feed, poultry feed, aquatic feed, ruminant, and other products; and operates pig breeding farms. The company also engages in the pig slaughtering … Read more